Please login to read the full article.
Scrip Regulatory Affairs
Distracting factors in drug ads on TV: US FDA seeks feedback on study results
06 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA report assesses how to improve risk-benefit communication in promo material for Rx drugs
- US FDA consults on selective collection of safety data in drug trials
- US FDA guidance explains how to display proprietary and established drug names in promotional material
- US FDA finalises stricter rules on disqualifying clinical investigators in drug, device studies
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
